Glutamate forward and reverse transport: From molecular mechanism to transporter‐mediated release after ischemia
Citations Over TimeTop 11% of 2008 papers
Abstract
Glutamate transporters remove the excitatory neurotransmitter glutamate from the extracellular space after neurotransmission is complete, by taking glutamate up into neurons and glia cells. As thermodynamic machines, these transporters can also run in reverse, releasing glutamate into the extracellular space. Because glutamate is excitotoxic, this transporter-mediated release is detrimental to the health of neurons and axons, and it, thus, contributes to the brain damage that typically follows a stroke. This review highlights current ideas about the molecular mechanisms underlying glutamate uptake and glutamate reverse transport. It also discusses the implications of transporter-mediated glutamate release for cellular function under physiological and patho-physiological conditions.
Related Papers
- → Astrocyte Glutamate Uptake and Signaling as Novel Targets for Antiepileptogenic Therapy(2020)67 cited
- → The Activation of Metabotropic Glutamate Receptors Protects Nerve Cells from Oxidative Stress(1998)150 cited
- → Group I Metabotropic Glutamate Receptors Mediate a Dual Role of Glutamate in T Cell Activation(2004)127 cited
- → Mechanisms Associated with Activation of Intracellular Metabotropic Glutamate Receptor, mGluR5(2016)19 cited
- → A group I metabotropic glutamate receptor controls synaptic gain between rods and rod bipolar cells in the mouse retina(2018)7 cited